KAYLA ESHAM: Open Payments
NPI 1336613389 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$740 in 31 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $336 · 2025 $740
Food & beverage: $740
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 7 | $132 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $128 |
| Medtronic, Inc. | 1 | $110 |
| Novartis Pharmaceuticals Corporation | 4 | $95 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
| Alnylam Pharmaceuticals Inc. | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Amgen Inc. | 2 | $37 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $23 |
| Novo Nordisk Inc | 1 | $22 |
Products named: JARDIANCE, AURORA EV-ICD MRI SURESCAN, LEQVIO, ELIQUIS, Kerendia, VYNDAQEL, CAMZYOS, REPATHA.
Industry payments across MD — which companies pay providers there.
